{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T01:40:41Z","timestamp":1760665241834,"version":"build-2065373602"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,16]]},"DOI":"10.7759\/cureus.94752","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T01:25:14Z","timestamp":1760664314000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond SSRIs: Exploring Hormonal Therapy for Mood Disorders in Perimenopause and Postmenopause"],"prefix":"10.7759","author":[{"given":"Raja","family":"Mogallapu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Sarich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Chalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ang-Rabanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata","family":"Sugnanam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijaya Krishna Prasad","family":"Vudathaneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.4.375","article-title":"Associations of hormones and menopausal status with depressed mood in women with no history of depression","volume":"63","author":"Freeman EW","year":"2006","unstructured":"Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006, 63:375-82. 10.1001\/archpsyc.63.4.375","journal-title":"Arch Gen Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.0111","article-title":"Effects of estradiol withdrawal on mood in women with past perimenopausal depression: a randomized clinical trial","volume":"72","author":"Schmidt PJ","year":"2015","unstructured":"Schmidt PJ, Ben Dor R, Martinez PE, et al.. Effects of estradiol withdrawal on mood in women with past perimenopausal depression: a randomized clinical trial. JAMA Psychiatry. 2015, 72:714-26. 10.1001\/jamapsychiatry.2015.0111","journal-title":"JAMA Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0148-z","article-title":"Sex differences and the neurobiology of affective disorders","volume":"44","author":"Rubinow DR","year":"2019","unstructured":"Rubinow DR, Schmidt PJ. Sex differences and the neurobiology of affective disorders. Neuropsychopharmacol. 2019, 44:111-28. 10.1038\/s41386-018-0148-z","journal-title":"Neuropsychopharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1808","article-title":"Menopause effects on verbal memory: findings from a longitudinal community cohort","volume":"98","author":"Epperson CN","year":"2013","unstructured":"Epperson CN, Sammel MD, Freeman EW. Menopause effects on verbal memory: findings from a longitudinal community cohort. J Clin Endocrinol Metab. 2013, 98:3829-38. 10.1210\/jc.2013-1808","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000528","article-title":"Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition","volume":"23","author":"Gordon JL","year":"2016","unstructured":"Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Leserman J, Girdler SS. Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition. Menopause. 2016, 23:257-66. 10.1097\/GME.0000000000000528","journal-title":"Menopause"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000193","article-title":"Mood disorders in midlife women: understanding the critical window and its clinical implications","volume":"21","author":"Soares CN","year":"2014","unstructured":"Soares CN. Mood disorders in midlife women: understanding the critical window and its clinical implications. Menopause. 2014, 21:198-206. 10.1097\/GME.0000000000000193","journal-title":"Menopause"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e3181db9f8b","article-title":"Associations of depression with the transition to menopause","volume":"17","author":"Freeman EW","year":"2010","unstructured":"Freeman EW. Associations of depression with the transition to menopause. Menopause. 2010, 17:823-7. 10.1097\/gme.0b013e3181db9f8b","journal-title":"Menopause"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2011.05.011","article-title":"Mood and menopause: findings from the Study of Women's Health Across the Nation (SWAN) over 10 years","volume":"38","author":"Bromberger JT","year":"2011","unstructured":"Bromberger JT, Kravitz HM. Mood and menopause: findings from the Study of Women's Health Across the Nation (SWAN) over 10 years. Obstet Gynecol Clin North Am. 2011, 38:609-25. 10.1016\/j.ogc.2011.05.011","journal-title":"Obstet Gynecol Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-014-0517-1","article-title":"Hormone replacement therapy in the treatment of perimenopausal depression","volume":"16","author":"Gordon JL","year":"2014","unstructured":"Gordon JL, Girdler SS. Hormone replacement therapy in the treatment of perimenopausal depression. Curr Psychiatry Rep. 2014, 16:517. 10.1007\/s11920-014-0517-1","journal-title":"Curr Psychiatry Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2015.05.001","article-title":"Menopausal symptoms and their management","volume":"44","author":"Santoro N","year":"2015","unstructured":"Santoro N, Epperson CN, Mathews SB. Menopausal symptoms and their management. Endocrinol Metab Clin North Am. 2015, 44:497-515. 10.1016\/j.ecl.2015.05.001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"Canonico M","year":"2008","unstructured":"Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. Br Med J. 2008, 336:1227-31. 10.1136\/bmj.39555.441944.BE","journal-title":"Br Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2017.1291607","article-title":"Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol\u2009\u00b1\u2009progesterone) are optimal","volume":"20","author":"L'Hermite M","year":"2017","unstructured":"L'Hermite M. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol\u2009\u00b1\u2009progesterone) are optimal. Climacteric. 2017, 20:331-8. 10.1080\/13697137.2017.1291607","journal-title":"Climacteric"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.106004","article-title":"Estrogen replacement in perimenopause-related depression: a preliminary report","volume":"183","author":"Schmidt PJ","year":"2000","unstructured":"Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol. 2000, 183:414-20. 10.1067\/mob.2000.106004","journal-title":"Am J Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.3998","article-title":"Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial","volume":"75","author":"Gordon JL","year":"2018","unstructured":"Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Xia K, Schmidt PJ, Girdler SS. Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial. JAMA Psychiatry. 2018, 75:149-57. 10.1001\/jamapsychiatry.2017.3998","journal-title":"JAMA Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2004.07.003","article-title":"Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone","volume":"30","author":"Andr\u00e9en L","year":"2005","unstructured":"Andr\u00e9en L, Sundstr\u00f6m-Poromaa I, Bixo M, Andersson A, Nyberg S, B\u00e4ckstr\u00f6m T. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrinology. 2005, 30:212-24. 10.1016\/j.psyneuen.2004.07.003","journal-title":"Psychoneuroendocrinology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014624.pub2","article-title":"Brexanolone, zuranolone and related neurosteroid GABA(A) receptor positive allosteric modulators for postnatal depression","volume":"6","author":"Wilson CA","year":"2025","unstructured":"Wilson CA, Robertson L, Ayre K, Hendon JL, Dawson S, Bridges C, Khalifeh H. Brexanolone, zuranolone and related neurosteroid GABA(A) receptor positive allosteric modulators for postnatal depression. Cochrane Database Syst Rev. 2025, 6:CD014624. 10.1002\/14651858.CD014624.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail MH","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989, 81:1879-86. 10.1093\/jnci\/81.24.1879","journal-title":"J Natl Cancer Inst"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"129","author":"Goff DC Jr","year":"2014","unstructured":"Goff DC Jr, Lloyd-Jones DM, Bennett G, et al.. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines. Circ. 2014, 129:S49-73. 10.1161\/01.cir.0000437741.48606.98","journal-title":"Circ"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000002200","article-title":"The 2023 nonhormone therapy position statement of The North American Menopause Society","volume":"30","author":"The North American Menopause Society","year":"2023","unstructured":"The North American Menopause Society. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023, 30:573-90. 10.1097\/GME.0000000000002200","journal-title":"Menopause"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000319","article-title":"The North American Menopause Society recommendations for clinical care of midlife women","volume":"21","author":"Shifren JL","year":"2014","unstructured":"Shifren JL, Gass ML. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2014, 21:1038-62. 10.1097\/GME.0000000000000319","journal-title":"Menopause"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0172-0","article-title":"Development and validation of a new rating scale for perimenopausal depression-the Meno-D","volume":"8","author":"Kulkarni J","year":"2018","unstructured":"Kulkarni J, Gavrilidis E, Hudaib AR, Bleeker C, Worsley R, Gurvich C. Development and validation of a new rating scale for perimenopausal depression-the Meno-D. Transl Psychiatry. 2018, 8:123. 10.1038\/s41398-018-0172-0","journal-title":"Transl Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-1-28","article-title":"International versions of the Menopause Rating Scale (MRS)","volume":"1","author":"Heinemann LA","year":"2003","unstructured":"Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes. 2003, 1:28. 10.1186\/1477-7525-1-28","journal-title":"Health Qual Life Outcomes"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/393394-beyond-ssris-exploring-hormonal-therapy-for-mood-disorders-in-perimenopause-and-postmenopause","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T01:25:15Z","timestamp":1760664315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/393394-beyond-ssris-exploring-hormonal-therapy-for-mood-disorders-in-perimenopause-and-postmenopause"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.94752","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,16]]}}}